Lice Treatment Market Forecasts to 2030 - Global Analysis By Product, Treatment Method, Formulation, Distribution Channel, Application, End User and By Geography

According to Stratistics MRC, the Global Lice Treatment Market is accounted for $1.28 billion in 2024 and is expected to reach $1.76 billion by 2030 growing at a CAGR of 6.5% during the forecast period. Lice treatment involves the removal or eradication of parasitic lice infestations, typically found on the scalp, body, or pubic area. This process commonly includes the use of medicated shampoos, creams, or lotions containing chemicals like permethrin or pyrethrin to kill the lice and their eggs (nits). Additionally, combing through the hair with a fine-toothed comb to physically remove lice and nits is often recommended. Proper hygiene practices and thorough cleaning of personal items such as bedding, clothing, and hair accessories are essential to prevent reinfestation and ensure effective treatment.

According to a CDC article published in August 2021, Lice Clinics of America have accomplished administering over 750,000 effective head lice treatments through the utilization of heated air, with a success rate beyond 99 percent.

Market Dynamics:

Driver:

High prevalence of lice infestations

Increased instances of infestations create a greater demand for treatment solutions, including medicated shampoos, creams, and specialized combs. This demand encourages innovation and investment in research and development, leading to the introduction of more effective and convenient treatment options. Furthermore, heightened awareness of the problem among healthcare professionals and the public amplifies the adoption of lice treatment products, ultimately fueling market growth and expansion to cater to the rising needs.

Restraint:

Concerns about potential side effects

Concerns about potential side effects in lice treatment include skin irritation, allergic reactions, and toxicity from chemical ingredients like permethrin or pyrethrin. These worries can deter individuals from using conventional treatments, leading to a preference for alternative remedies or avoidance of treatment altogether. Such hesitations diminish market growth by reducing demand for pharmaceutical lice treatment products, thereby limiting revenue generation for manufacturers and impeding market expansion.

Opportunity:

Rising healthcare expenditure

With more financial resources allocated to healthcare, individuals and healthcare systems are better equipped to purchase lice treatment medications, shampoos, and related products. Additionally, greater investment in healthcare infrastructure often leads to improved awareness campaigns, educational programs, and healthcare facilities specializing in dermatology and infectious diseases, all of which contribute to a higher demand for lice treatment solutions. This trend ultimately supports the expansion of the lice treatment market.

Threat:

Growing popularity of home remedies

The growing popularity of home remedies for lice treatment undermines the market by diverting demand away from pharmaceutical products. Home remedies compete directly with traditional treatments, reducing sales for pharmaceutical companies. Moreover, reliance on unverified home remedies can prolong infestations, exacerbating the spread of lice. This shift in consumer preference limits market growth by diminishing the adoption of medically proven treatments and hindering revenue opportunities for lice treatment manufacturers.

Covid-19 Impact

The covid-19 pandemic has had a mixed impact on the lice treatment market. While increased hygiene awareness and social distancing measures initially reduced lice transmission rates, disruptions in healthcare access and economic uncertainty have hindered market growth. Additionally, shifts towards remote work and virtual schooling may have altered lice exposure dynamics. Overall, the pandemic has introduced complexities such as supply chain disruptions and changes in consumer behaviour, influencing the lice treatment market unpredictably.

The chemical treatments segment is expected to be the largest during the forecast period

The chemical treatments segment is estimated to have a lucrative growth. Chemical lice treatments typically contain insecticidal agents like permethrin or pyrethrin, which target and kill lice and their eggs. These products are available in various forms such as shampoos, creams, or lotions and are applied directly to the scalp or affected area. While effective, concerns about potential side effects, such as skin irritation or toxicity, have led to hesitations in usage. Resistance development among lice strains is also a growing challenge for chemical treatments.

The shampoos segment is expected to have the highest CAGR during the forecast period

The shampoos segment is anticipated to witness the highest CAGR growth during the forecast period. Lice treatment shampoos are formulated with active ingredients like permethrin or pyrethrin, which kill lice and their eggs (nits). These shampoos are applied to wet hair, left on for a specified duration, and then rinsed out. Some formulations may require repeat applications to ensure thorough eradication. While effective, concerns about chemical exposure and the development of resistance have prompted the development of alternative treatments, including natural or enzyme-based shampoos.

Region with largest share:

Asia Pacific is projected to hold the largest market share during the forecast period due to population density, hygiene practices, and economic development. With densely populated areas and varying levels of access to healthcare, demand for lice treatment products fluctuates across countries. Rapid urbanization and increasing disposable income in some areas also drive market growth. Additionally, government initiatives and healthcare infrastructure improvements play pivotal roles in shaping the market landscape across the Asia-Pacific region.

Region with highest CAGR:

North America is projected to have the highest CAGR over the forecast period, owing to increasing awareness about hygiene and healthcare standards. Rising incidence of lice infestations, particularly among children in school settings, fuels market expansion. Moreover, technological advancements and the introduction of organic and natural remedies further diversify the market landscape. With a focus on efficacy, safety, and convenience, stakeholders continually innovate to address evolving consumer needs, fostering sustained market growth in North America.

Key players in the market

Some of the key players profiled in the Lice Treatment Market include Prestige Brands Holdings, Inc., Bayer AG, Sanofi SA, Perrigo Company plc, Insight Pharmaceuticals Corporation, Reckitt Benckiser Group plc, Arbor Pharmaceuticals, LLC, Tec Laboratories, Inc., Tyratech Inc., Quantum Health, Alliance Pharma plc, Omega Pharma, Thornton & Ross Ltd, LaCorium Health, Luminox Healthcare and ParaPRO LLC.

Key Developments:

In April 2022, Arbor Development LLC announced the completion of the third-party clinical study that exhibits a remarkable 95% efficacy rate through the utilization of their cutting-edge, exclusive technology H.A.L.T.

In August 2021, ParaPRO announced the U.S. FDA approval for Natroba (spinosad) Topical Suspension, 0.9%, making it the inaugural product for treating scabies now accessible within the United States.

Products Covered:

• Topical Treatments
• Oral Medications
• Home Remedies
• Lice Combs
• Other Products

Treatment Methods Covered:

• Chemical Treatments
• Physical Treatments

Formulations Covered:

• Shampoos
• Creams & Lotions
• Gels
• Sprays
• Other Formulations

Distribution Channels Covered:

• Pharmacies & Drugstores
• Online Retail
• Hospitals & Clinics
• Other Distribution Channels

Applications Covered:

• Humans
• Animals
• Crops

End Users Covered:

• Homecare Settings
• Salons & Hair Care Centers
• Community Health Centers
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances